⏳ Disponible en 10 días.
Despacho diferido: este producto se envía cuando ingresa stock.

Ficha técnica
• Autor: AA. VV.
• Páginas: 354
• Formato: 22,9 x 15,2 cm
• Encuadernación: Tapa blanda
• ISBN: 9780309224185

Sinopsis
Technologies collectively called omics enable simultaneous measurement of an enormous number of biomolecules; for example, genomics investigates thousands of DNA sequences, and proteomics examines large numbers of proteins. Scientists are using these technologies to develop innovative tests to detect disease and to predict a patient's likelihood of responding to specific drugs. Following a recent case involving premature use of omics-based tests in cancer clinical trials at Duke University, the NCI requested that the IOM establish a committee to recommend ways to strengthen omics-based test development and evaluation. This report identifies best practices to enhance development, evaluation, and translation of omics-based tests while simultaneously reinforcing steps to ensure that these tests are appropriately assessed for scientific validity before they are used to guide patient treatment in clinical trials.